THE EFFECT OF REDUCED-DOSE ORAL GLUCOCORTICOIDS DURING INDUCTION OF REMISSION INDUCTION IN SEVERE ANCA-ASSOCIATED VASCULITIS

被引：0
|
作者：
Walsh, Michael [1 ]
Merkel, Peter [2 ]
Jayne, David [3 ]
机构：
[1] McMaster Univ, St Josephs Healthcare, Hamilton, ON, Canada
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Univ Cambridge, Addenbrookes Hosp, Cambridge, England
来源：
RHEUMATOLOGY | 2019年 / 58卷
基金：
美国国家卫生研究院; 加拿大健康研究院; 英国医学研究理事会; 芬兰科学院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
361
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Failure of pneumococcal immunization during remission induction treatment of ANCA-associated vasculitis: The Pneumovas Pilot 1 study
    Groh, Matthieu
    Puechal, Xavier
    Terrier, Benjamin
    Le Jeunne, Claire
    Batteux, Frederic
    Launay, Odile
    JOINT BONE SPINE, 2017, 84 (05) : 643 - 644
  • [42] Single-dose rituximab for remission induction and maintenance therapy in ANCA-associated vasculitis: a retrospective analysis of 17 patients
    Moog, P.
    Probst, M.
    Kuechle, C.
    Hauser, C.
    Heemann, U.
    Thuermel, K.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 (06) : 519 - 523
  • [43] Practice Patterns of Induction Therapy in Severe ANCA-Associated Vasculitis: An International Physician Survey
    Xu, Lillian
    Aqeel, Faten F.
    Tomar, Ojaswi S.
    Li, Tingting
    Geetha, Duvuru
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 190 - 191
  • [44] LOW-DOSE RITUXIMAB AS INDUCTION THERAPY FOR JAPANESE PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Takakuwa, Y.
    Hanaoka, H.
    Kiyokawa, T.
    Ishimori, K.
    Iida, H.
    Nagafuchi, H.
    Okazaki, T.
    Ozaki, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1260 - 1260
  • [45] Plasma exchange and low cyclophosphamide dose in induction treatment of ANCA-associated systemic vasculitis
    Szpirt, Wladimir M.
    Krarup, Elisabeth
    Egfjord, Martin
    APMIS, 2009, 117 : 75 - 75
  • [46] Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up
    Harper, Lorraine
    Morgan, Matthew D.
    Walsh, Michael
    Hoglund, Peter
    Westman, Kerstin
    Flossmann, Oliver
    Tesar, Vladimir
    Vanhille, Phillipe
    de Groot, Kirsten
    Luqmani, Raashid
    Felipe Flores-Suarez, Luis
    Watts, Richard
    Pusey, Charles
    Bruchfeld, Annette
    Rasmussen, Niels
    Blockmans, Daniel
    Savage, Caroline O.
    Jayne, David
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) : 955 - 960
  • [47] Casivirimab/Imdevimab for severe COVID-19 Pneumonia during Rituximab Induction Therapy for ANCA-associated Vasculitis
    Herold, J.
    Zwickel, P.
    Geis, F.
    van Drongelen, N.
    Rosenberg, M.
    Buettner, S.
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2021, 116 (SUPPL 2) : 54 - 55
  • [48] The Effect of Cumulative UVB Dose on ANCA-Associated Vasculitis
    Scott, Jennifer
    Havyarimana, Enock
    Navarro-Gallinad, Albert
    Wyse, Jason
    van Geffen, Jos
    Buettner, Antonia
    Wanigasekera, Tamara
    Aslett, Louis J.
    Basu, Neil
    Zgaga, Lina
    Little, Mark A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 503 - 504
  • [49] Diffuse Alveolar Hemorrhage Secondary To Anca-Associated Vasculitis: Role Of Plasma Exchange And Induction Of Remission Therapy
    Cartin-Ceba, R.
    Diaz-Caballero, L. A.
    Al-Qadi, M. O.
    Tryfon, S.
    Fervenza, F. C.
    Ytterberg, S. R.
    Specks, U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [50] Serum B cell activating factor (BAFF) as a biomarker for induction of remission with rituximab in ANCA-associated vasculitis
    Tsuboi, Kazuyuki
    Noguchi, Kazuteru
    Kitano, Masayasu
    Furukawa, Tetsuya
    Hashimoto, Teppei
    Azuma, Naoto
    Matsui, Kiyoshi
    IMMUNOLOGICAL MEDICINE, 2022, 45 (04) : 238 - 243
12345